Stock Analysts

Solid Quarter at ALKS, View Backed (ALKS) (AMLN) (ELN) (JNJ)

Alkermes plc ( ALKS ) reported earnings of 28 cents per share (including depreciation and stock-based compensation expenses) in the first-quarter of fiscal 2013 (ended June 30, 2012). The Zacks Consensus Estimate was 10 cents per share. This was the third full quarter following the purchase of Elan Corporation ’s ( ELN ) drug delivery unit, Elan Drug Technologies (EDT). […]

Downgrades

ENERSYS INC (ENS) Downgraded by Zacks to NEUTRAL

Zacks Investment Research downgraded shares of ENERSYS INC (ENS) from OUTPERFORM to NEUTRAL on July 31, 2012, with a target price of $38.80. EnerSys is a global leader in stored energy solutions for industrial applications. They complement their extensive line of motive power, reserve power, and specialty batteries with a full range of integrated services and systems. […]

Downgrades

RIMAGE CORP (RIMG) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of RIMAGE CORP (RIMG) from NEUTRAL to UNDERPERFORM on July 31, 2012, with a target price of $6.50. Rimage Corporation designs, manufactures and markets CD recordable (CD-R) and computer diskette duplication and production equipment and provides high volume data duplication services on diskette, CD-R and CD-ROM. The company's producer line of CD-R production systems provides turnkey premastering, recording and label printing in a single machine that may be used alone or on a network to allow the user to record and label large volumes of digital information for information distribution, archiving and other applications. […]

Stock Analysts

Cummins Beats EPS, Misses Sales (CAT) (CMI) (NAV)

Cummins Inc. ( CMI ) reported a 2% rise in adjusted earnings per share to $2.45 in the second quarter of 2012 from $2.41 in the year-ago quarter despite a fall in net income to $465 million from $468 million in the second quarter of 2011. With this, it surpassed the Zacks Consensus Estimate by 18 cents […]

Stock Analysts

MWI Vet Supply Beats, Ups Guidance (HSIC) (MWIV)

MWI Veterinary Supply ’s ( MWIV ) third quarter 2012 EPS came in at $1.15, surpassing the Zacks Consensus Estimate of $1.06 and increased 26.4% year over year. The company reported a robust 35% increase in revenues to $554.7 million and comfortably surpassed the Zacks Consensus Estimate of $514 million. […]

Stock Analysts

Earnings Preview: CBS Corp. (CBS) (CMCSA) (NWSA)

CBS Corporation ( CBS ), one of the leading media company in United States and worldwide, is expected to release its second-quarter 2012 financial results on Thursday, August 2, 2012, after the market closes. The Zacks Consensus Estimate for second quarter 2012 stands at 58 cents, flat year over year. The estimate lies between a low of 54 cents and a high of 64 cents. […]

Stock Analysts

Regeneron Gets CRL (REGN)

Regeneron Pharmaceuticals Inc. ( REGN ) recently suffered a setback in its efforts to expand the label of its drug Arcalyst. The US Food and Drug Administration (FDA) declined to approve Arcalyst for preventing gout flares in patients initiating uric acid-lowering therapy on the basis of the submitted data […]

Genworth Financial Announces Second Quarter 2012 Results

Genworth Financial Announces Second Quarter 2012 Results U.S. Mortgage Insurance Results Continue To Improve; North Carolina Statutory Capital Waiver Extended Through July 31, 2014 Australia Claim Development In Line With First Quarter 2012 Reserve Strengthening Taking Steps To Improve Long Term Care Profitability Through Premium Rate Increases & Product Changes PR Newswire RICHMOND, Va., July 31, 2012 RICHMOND, Va. , July 31, 2012 /PRNewswire/ — Genworth Financial, Inc […]

FDA Approval

Depomed Announces Submission Of Serada NDA

Depomed Announces Submission Of Serada NDA PR Newswire MENLO PARK, Calif., July 31, 2012 MENLO PARK, Calif. , July 31, 2012 /PRNewswire/ — Depomed, Inc. (Nasdaq: DEPO) today announced that it has submitted a New Drug Application (NDA) for Serada to the United States Food and Drug Administration. […]

Stock Analysts

Cerner Inks Deal with CAMH, Canada (ATHN) (CERN) (MDRX) (QSII)

Leading healthcare information technology (“HCIT”) solutions provider, Cerner Corporation ( CERN ) recently reported that it inked an agreement with The Centre for Addiction and Mental Health (“CAMH”) of Canada to automate clinical data processes. CAMH will utilize Cerner’s Millennium architecture, a composite computing setup in health IT services. CAMH is a renowned research center for addiction and mental health. […]